November 2, 2012 – Molecular imaging with positron emission tomography (PET) has enabled scientists for the first time ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
October 25, 2012 — Lantheus Medical Imaging Inc. announced it has extended its contract with Nordion to supply ...
With its million-dollar scanners and their mushrooming use in recent years, medical imaging has become the poster child ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
September 14, 2012 — The U.S. Food and Drug Administration (FDA) has approved the production and use of Choline C-11 ...
September 12, 2012 – Positron Corp. announced that Jubilant DraxImage Inc., a Jubilant Life Sciences company, and ...
We want absolutes; things we can depend on; certainties in an unfortunately uncertain world. It’s the kind of faith we ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
August 27, 2012 — The growth rate of positron emission tomography (PET) and PET/computed tomography (CT) medical imaging ...
August 27, 2012 — Positron Corp., a molecular imaging healthcare company, announced the submission of a drug master file ...
August 24, 2012 — West Physics Consulting, a national provider of medical and health physics consulting and testing ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
August 21, 2012 — The U.S. Food and Drug Administration (FDA) granted marketing approval for cfrQuant, coronary flow ...
August 20, 2012 — Positron Corp. announced the use of its Attrius system at Caring Heart and Brain Imaging Inc. of ...
August 14, 2012 — Positron Corp. announced the transfer, consolidation and integration of its radiopharmaceutical ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
August 3, 2012 — FluoroPharma Medical Inc., a company specializing in the development of novel diagnostic imaging ...
When I was a kid, living in a mid-size Wisconsin town, my family would drive the mile or so from our home to the Lake ...
July 25, 2012 — Positron Corp. announced approval of a pledge for $15 million in tax increment financing (TIF) bonds ...
The last 20 years have brought about great advances in breast cancer detection and treatment. Among them has been the ...
July 24, 2012 — Navidea Biopharmaceuticals Inc., a specialty pharmaceutical company focused on precision diagnostic ...
July 23, 2012 — GE Healthcare announced the final results from a Phase III study of the investigational PET (positron ...
July 13, 2012 — Royal Philips Electronics announced that it has embarked on a five-year joint research and development ...
June 20, 2012 — The Society of Nuclear Medicine’s (SNM) 2012 Image of the Year illustrates the effectiveness of Bi-213 ...
November 02, 2012 